Mowery Clinic Llc - Medicare Primary Care in Salina, KS

Mowery Clinic Llc is a medicare enrolled primary clinic (Internal Medicine) in Salina, Kansas. The current practice location for Mowery Clinic Llc is 737 E Crawford St, Salina, Kansas. For appointments, you can reach them via phone at (785) 827-7261. The mailing address for Mowery Clinic Llc is 737 E Crawford St, Salina, Kansas and phone number is (785) 827-7261.

Mowery Clinic Llc is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1790742278. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (785) 827-7261.

Contact Information

Mowery Clinic Llc
737 E Crawford St
Salina
KS 67401-5103
(785) 827-7261
(785) 827-6334

Primary Care Clinic Profile

Full NameMowery Clinic Llc
SpecialityInternal Medicine
Location737 E Crawford St, Salina, Kansas
Authorized Official Name and PositionJennifer L Vonlintel (ADMINISTRATOR)
Authorized Official Contact7858220261
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mowery Clinic Llc
737 E Crawford St
Salina
KS 67401-5103

Ph: (785) 827-7261
Mowery Clinic Llc
737 E Crawford St
Salina
KS 67401-5103

Ph: (785) 827-7261

NPI Details:

NPI Number1790742278
Provider Enumeration Date04/27/2006
Last Update Date11/20/2013

Medicare PECOS Information:

Medicare PECOS PAC ID3375539349
Medicare Enrollment IDO20040423000937

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Medical Identifiers

Medical identifiers for Mowery Clinic Llc such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1790742278NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine (* (Not Available))Primary
207RC0000XInternal Medicine - Cardiovascular Disease (* (Not Available))Secondary
207RE0101XInternal Medicine - Endocrinology, Diabetes & Metabolism (* (Not Available))Secondary
207RG0100XInternal Medicine - Gastroenterology (* (Not Available))Secondary
207RH0003XInternal Medicine - Hematology & Oncology (* (Not Available))Secondary
207RI0011XInternal Medicine - Interventional Cardiology (* (Not Available))Secondary
207RN0300XInternal Medicine - Nephrology (* (Not Available))Secondary
207RP1001XInternal Medicine - Pulmonary Disease (* (Not Available))Secondary
207RX0202XInternal Medicine - Medical Oncology (* (Not Available))Secondary
207V00000XObstetrics & Gynecology (* (Not Available))Secondary
208000000XPediatrics (* (Not Available))Secondary
208600000XSurgery (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Mowery Clinic Llc acts as a billing entity for following providers:
Provider NameDavid Battin
Provider TypePractitioner - Interventional Cardiology
Provider IdentifiersNPI Number: 1700881000
PECOS PAC ID: 2860466976
Enrollment ID: I20040824001028

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameEarl H Matthews
Provider TypePractitioner - General Surgery
Provider IdentifiersNPI Number: 1659337079
PECOS PAC ID: 6800842907
Enrollment ID: I20050322000793

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NamePaul A Johnson
Provider TypePractitioner - Gastroenterology
Provider IdentifiersNPI Number: 1720043045
PECOS PAC ID: 3375580798
Enrollment ID: I20050415000797

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameRichard A Yaple
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1730187329
PECOS PAC ID: 6103714522
Enrollment ID: I20050420000572

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameMark T Mikinski
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1467418897
PECOS PAC ID: 8820907975
Enrollment ID: I20050520000389

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameDavid T Dennis
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1447215827
PECOS PAC ID: 0941242788
Enrollment ID: I20050523000826

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameJeffrey B Knox
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1437114329
PECOS PAC ID: 9537101373
Enrollment ID: I20050523000850

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameLavelle A Ellis
Provider TypePractitioner - Gastroenterology
Provider IdentifiersNPI Number: 1265497002
PECOS PAC ID: 9739122474
Enrollment ID: I20050603000769

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameJoel Parriott
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1821054586
PECOS PAC ID: 2961310735
Enrollment ID: I20050615000425

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameKaril L Bellah
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1518921485
PECOS PAC ID: 4789620212
Enrollment ID: I20050706000403

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameNatalie A Morgan
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1255361119
PECOS PAC ID: 5890718134
Enrollment ID: I20060824000089

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameKenneth T Smith
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1396851689
PECOS PAC ID: 8426055799
Enrollment ID: I20061030000172

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameHenry S Reed
Provider TypePractitioner - Nephrology
Provider IdentifiersNPI Number: 1679612964
PECOS PAC ID: 0042385932
Enrollment ID: I20080812000164

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameBrian S Pavey
Provider TypePractitioner - Nephrology
Provider IdentifiersNPI Number: 1447361373
PECOS PAC ID: 7012068224
Enrollment ID: I20090630000122

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameChristopher A Rupe
Provider TypePractitioner - General Surgery
Provider IdentifiersNPI Number: 1740401249
PECOS PAC ID: 1658423959
Enrollment ID: I20090717000170

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameCurtis D Kauer
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1841255262
PECOS PAC ID: 4587702212
Enrollment ID: I20091117000390

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameDavid C Prendergast
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1841256930
PECOS PAC ID: 7810039641
Enrollment ID: I20100116000277

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameWilliam D Buck
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1023060902
PECOS PAC ID: 8628111218
Enrollment ID: I20100204000392

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameLeslie A Ablard
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1932368255
PECOS PAC ID: 1658496716
Enrollment ID: I20100913000594

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameRichard J Markiewicz
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1780725580
PECOS PAC ID: 0345279725
Enrollment ID: I20101025001405

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameRenee A Davis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1649577404
PECOS PAC ID: 3173705183
Enrollment ID: I20110314000064

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameLeslie Mack
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1508172552
PECOS PAC ID: 1456538669
Enrollment ID: I20110615000210

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameKevin Heath
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1326263781
PECOS PAC ID: 5092985820
Enrollment ID: I20130909000325

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameJacob Taylor Hodges
Provider TypePractitioner - Infectious Disease
Provider IdentifiersNPI Number: 1215162110
PECOS PAC ID: 8022255504
Enrollment ID: I20140710002412

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameDebra M Lyne
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1558760074
PECOS PAC ID: 9638391246
Enrollment ID: I20141117000228

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameMark Edward Banker
Provider TypePractitioner - General Surgery
Provider IdentifiersNPI Number: 1811288160
PECOS PAC ID: 8527353705
Enrollment ID: I20160826001701

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameMaria Baldasare
Provider TypePractitioner - Cardiovascular Disease (cardiology)
Provider IdentifiersNPI Number: 1790914372
PECOS PAC ID: 6103040472
Enrollment ID: I20160921002445

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameRajan I Mehta
Provider TypePractitioner - Allergy/immunology
Provider IdentifiersNPI Number: 1659354843
PECOS PAC ID: 7810163037
Enrollment ID: I20160921002580

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameCierra L Johnson
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1013327659
PECOS PAC ID: 3375845241
Enrollment ID: I20170612000094

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameJesica R Brown
Provider TypePractitioner - Gastroenterology
Provider IdentifiersNPI Number: 1700173754
PECOS PAC ID: 4486950805
Enrollment ID: I20170612000117

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameAndrew R Ross
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1598146409
PECOS PAC ID: 7517271448
Enrollment ID: I20180706001195

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameTawni S Lehecka
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1588223366
PECOS PAC ID: 6901130863
Enrollment ID: I20190626001578

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameAshley R Mather
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1235691346
PECOS PAC ID: 9537498035
Enrollment ID: I20190909003005

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameAmy M Radatz
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1972145803
PECOS PAC ID: 3870825128
Enrollment ID: I20191106000712

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameNicholas D Raasch
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1164870655
PECOS PAC ID: 4385938026
Enrollment ID: I20200728004007

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameMegan Morriss
Provider TypePractitioner - General Surgery
Provider IdentifiersNPI Number: 1548642291
PECOS PAC ID: 8527372614
Enrollment ID: I20200820000349

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameApril S Leonard
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1679165344
PECOS PAC ID: 5991112443
Enrollment ID: I20210329001538

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameAndrew J Westbrook
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1376072751
PECOS PAC ID: 8224309380
Enrollment ID: I20210802000921

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameKeenan C Wanamaker
Provider TypePractitioner - Vascular Surgery
Provider IdentifiersNPI Number: 1972508968
PECOS PAC ID: 1658364336
Enrollment ID: I20220505002561

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameBenjamin R Rahoy
Provider TypePractitioner - Allergy/immunology
Provider IdentifiersNPI Number: 1659891281
PECOS PAC ID: 7214201631
Enrollment ID: I20221103002211

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameMariah D Jones-greif
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1497312961
PECOS PAC ID: 1355677006
Enrollment ID: I20230522001401

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

Provider NameEmma L Kester
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1568084432
PECOS PAC ID: 2062837396
Enrollment ID: I20230726000372

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more Medical News

› Verified 9 days ago

News Archive

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar Therapeutics announced today new data from an investigator-sponsored Phase 2 study of NKTR-102 (etirinotecan pegol) in patients with Avastin-refractory high-grade glioma conducted at Stanford Cancer Institute under the direction of Lawrence Recht, M.D., Professor of Neurology and Neurosurgery, with co-investigator Seema Nagpal, M.D., Clinical Assistant Professor of Neurology and Neurological Sciences, Stanford School of Medicine.

Exchange of E. coli between humans and chimps in Uganda

Scientists from the University of Illinois at Champaign-Urbana have found that people employed in chimpanzee-focused research and tourism in a park in western Uganda are exchanging gastrointestinal bacteria - specifically Escherichia coli - with local chimpanzee populations. And some of the E. coli strains migrating to chimps are resistant to antibiotics used by humans in Uganda.

Combination of vascular risk and brain amyloid levels may accelerate age-related cognitive decline

Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain.

KHN's ‘What the Health?': Dems agree to agree, but not on what to agree on

Meanwhile, Biden administration officials unveil plans to provide covid-19 vaccines to younger children without looking like they are prejudging the science, in an attempt to avoid the mixed messaging that presaged the rollout of booster doses for adults.

Read more News

› Verified 9 days ago


Internal Medicine in Salina, KS

Salina Clinic L.l.c.
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 501 S Santa Fe Ave, Suite 100, Salina, KS 67401
Phone: 785-827-9631    Fax: 785-827-0217
Salina Health Education Foundation
Primary Care Clinic
Medicare: Medicare Enrolled
Practice Location: 2676 Planet Ave, Salina, KS 67401
Phone: 785-825-7251    
Salina Clinic L.l.c Rural Health Clinic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 501 S Santa Fe Ave, 100, Salina, KS 67401
Phone: 785-827-9631    Fax: 785-827-0217
Providence Family Health Care Llc
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 211 Greenway Rd, Salina, KS 67401
Phone: 785-309-1166    
Comcare, P.a
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 617 E Elm St, Salina, KS 67401
Phone: 785-825-8221    Fax: 785-825-0644
Conner Chiropractic
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1493 E Iron Ave, Salina, KS 67401
Phone: 785-309-0696    
Salina Health Education Foundation
Primary Care Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 3030 Enterprise Dr, Salina, KS 67401
Phone: 785-825-7251    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.